Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells

Oncogene

Volumn 30, Issue 10, 2011, Pages 1205-1212

  Samuel, S ^a   Fan, F ^a   Dang, L H ^b   Xia, L ^a   Gaur, P ^a   Ellis, L M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

apoptosis; autocrine; chemosensitivity; colorectal cancer; intracrine; VEGF

Indexed keywords

CASPASE 3; FLUOROURACIL; PROTEIN BAX; SURVIVIN; VASCULOTROPIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; COLORECTAL CANCER; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952534370     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.496     Document Type: Article

References (31)

1. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G et al. (2001). Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 61: 5736-5740. (Pubitemid 32769088)
2. Barr MP, Bouchier-Hayes DJ, Harmey JJ. (2008). Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia. Int J Oncol 32: 41-48. (Pubitemid 351176060)
3. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM et al. (1997). Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 79: 233-269.
4. Calvani M, Trisciuoglio D, Bergamaschi C, Shoemaker RH, Melillo G. (2008). Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells. Cancer Res 68: 285-291. (Pubitemid 351380130)
5. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439. (Pubitemid 26102719)
6. Cohen GM. (1997). Caspases: the executioners of apoptosis. Biochem J 326(Pt 1): 1-16. (Pubitemid 27386911)
7. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ et al. (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478. (Pubitemid 19272234)
8. Cryns V, Yuan J. (1998). Proteases to die for. Genes Dev 12: 1551-1570. (Pubitemid 28299508)
9. Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, Bunz F et al. (2006). Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66: 1684-1936.
10. Dias S, Shmelkov SV, Lam G, Rafii S. (2002). VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood 99: 2532-2540. (Pubitemid 34525442)
11. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Staehler M et al. (2009). Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol 27: 3312-3318.
12. Fan F, Wey JS, McCarty MF, Belcheva A, Liu W, Bauer TW et al. (2005). Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 24: 2647-2653. (Pubitemid 40593092)
13. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS et al. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442. (Pubitemid 26102720)
14. Ferrara N, Gerber HP, LeCouter J. (2003). The biology of VEGF and its receptors. Nat Med 9: 669-676. (Pubitemid 36749215)
15. Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G et al. (2002). VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417: 954-958. (Pubitemid 34716872)
16. 0-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273: 30336-30343. (Pubitemid 28545503)
17. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814.
18. Hutchings H, Ortega N, Plouet J. (2003). Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J 17: 1520-1522.
19. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S et al. (2007a). Autocrine VEGF signaling is required for vascular home-ostasis. Cell 130: 691-703. (Pubitemid 47268059)
20. Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK et al. (2007b). Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med 4: e186.
21. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309. (Pubitemid 20066716)
22. Lichtenberger BM, Tan PK, Niederleithner H, Ferrara N, Petzelbauer P, Sibilia M. (2010). Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 140: 268-279.
23. 0 non-coding region of vascular endothelial growth factor mRNA. PLoS Med 5: e94.
24. Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM et al. (2001). Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 61: 2183-2188. (Pubitemid 32692045)
25. Pidgeon GP, Barr MP, Harmey JH, Foley DA, Bouchier-Hayes DJ. (2001). Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer 85: 273-278. (Pubitemid 32695751)
26. Rini BI, Halabi S, Rosenberg JE, Stadler WM, Vaena DA, Ou S-S et al. (2008). Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206. J Clin Oncol 26: 5422-5428.
27. Santos SC, Dias S. (2004). Internal and external autocrine VEGF/ KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood 103: 3883-3889. (Pubitemid 38596309)
28. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
29. Senger DR, Perruzzi CA, Feder J, Dvorak HF. (1986). A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46: 5629-5632. (Pubitemid 17177959)
30. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC et al. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954.
31. Vincent L, Jin DK, Karajannis MA, Shido K, Hooper AT, Rashbaum WK et al. (2005). Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells. Cancer Res 65: 3185-3192. (Pubitemid 40524600)